Dimethylthiocarbamoyl chloride, an pharmaceutical intermediate with great demand in 2021

Pharmaceutical intermediates are a kind of fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. In other words, an intermediate is a material produced in the process of an API that must undergo further molecular modification or refinement before becoming an API.

Pharmaceutical intermediates are in the middle of the industry chain, and the upstream and downstream of pharmaceutical intermediates are chemical raw material market and API market respectively. Chemical raw materials are mainly divided into inorganic chemical raw materials and organic chemical raw materials. China's production of chemical raw materials in recent years gradually increased, downstream is the API market. As one of the pillars of China's pharmaceutical industry strategy, the chemical API industry has formed a relatively complete industrial system through decades of development, which is characterized by large scale, low cost and high output.

The downstream industries closely related to the intermediates industry are the manufacturers of bulk drugs and preparations, mainly including chemical drugs, traditional Chinese medicine, biological products, etc. With the increasing population and aging trend, the pharmaceutical industry has great potential for development.

Looking into the future, as the world's largest pharmaceutical intermediates production and export region, China will benefit not only from the development of the domestic pharmaceutical market, but also the development of the global pharmaceutical market. With the progress of medicine, domestic and global drug r&d and production is expected to continue to grow, and the market size of pharmaceutical intermediates will continue to expand. In 2021, the impact of the global COVID-19 epidemic will continue. On the one hand, the production demand for COVID-19 vaccine is large, and on the other hand, the market demand for related drugs will also increase, which will drive the growth of the pharmaceutical intermediates market in China. It is expected that the market size of pharmaceutical intermediates in China will reach 220 billion yuan in 2021, and it is expected that the market size of pharmaceutical intermediates in China will exceed 290 billion yuan in 2026.